ITGBL1 and prostate carcinoma: First, they showed by co-immunoprecipitation that in the presence of Ca2+, ITGBL1 can directly interact with integrin β and inhibit its activity: depletion of ITGBL1 increased, whereas ITGBL1 overexpression reduced the amount of active integrin β in PC3 prostate cancer cells.